Literature DB >> 31560216

Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With High Bleeding Risk: Insight From the STOPDAPT-2 Trial.

Hirotoshi Watanabe1, Takenori Domei2, Takeshi Morimoto3, Masahiro Natsuaki4, Hiroki Shiomi1, Toshiaki Toyota5, Masanobu Ohya6, Satoru Suwa7, Kensuke Takagi8, Mamoru Nanasato9, Yoshiki Hata10, Masahiro Yagi11, Nobuhiro Suematsu12, Takafumi Yokomatsu13, Itaru Takamisawa9, Masayuki Doi14, Toshiyuki Noda15, Hideki Okayama16, Yoshitane Seino17, Tomohisa Tada18, Hiroki Sakamoto18, Kiyoshi Hibi19, Mitsuru Abe20, Kazuya Kawai21, Koichi Nakao22, Kenji Ando2, Kengo Tanabe23, Yuji Ikari24, Keiichi Igarashi Hanaoka25, Yoshihiro Morino26, Ken Kozuma27, Kazushige Kadota6, Yutaka Furukawa5, Yoshihisa Nakagawa28, Takeshi Kimura1.   

Abstract

Entities:  

Keywords:  hemorrhage; percutaneous coronary intervention; platelet aggregation inhibitors; stents; thrombosis

Year:  2019        PMID： 31560216     DOI： 10.1161/CIRCULATIONAHA.119.043613

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

Review 1.  P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention.

Authors:  Davide Capodanno; Usman Baber; Deepak L Bhatt; Jean-Philippe Collet; George Dangas; Francesco Franchi; C Michael Gibson; Hyeon-Cheol Gwon; Adnan Kastrati; Takeshi Kimura; Pedro A Lemos; Renato D Lopes; Roxana Mehran; Michelle L O'Donoghue; Sunil V Rao; Fabiana Rollini; Patrick W Serruys; Philippe G Steg; Robert F Storey; Marco Valgimigli; Pascal Vranckx; Hirotoshi Watanabe; Stephan Windecker; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2022-06-13       Impact factor: 32.419

2.  Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort.

Authors:  Yuki Obayashi; Hirotoshi Watanabe; Takeshi Morimoto; Ko Yamamoto; Masahiro Natsuaki; Takenori Domei; Kyohei Yamaji; Satoru Suwa; Tsuyoshi Isawa; Hiroki Watanabe; Ruka Yoshida; Hiroki Sakamoto; Masaharu Akao; Yoshiki Hata; Itsuro Morishima; Hideo Tokuyama; Masahiro Yagi; Hiroshi Suzuki; Kohei Wakabayashi; Nobuhiro Suematsu; Tsukasa Inada; Toshihiro Tamura; Hideki Okayama; Mitsuru Abe; Kazuya Kawai; Koichi Nakao; Kenji Ando; Kengo Tanabe; Yuji Ikari; Yoshihiro Morino; Kazushige Kadota; Yutaka Furukawa; Yoshihisa Nakagawa; Takeshi Kimura
Journal:  Circ Cardiovasc Interv       Date:  2022-08-01       Impact factor: 7.514

3.  Computer Simulation of Platelet Adhesion around Stent Struts in the Presence and Absence of Tissue Defects around Them.

Authors:  Yota Kawamura; Noriko Tamura; Shinichi Goto; Shinya Goto
Journal:  J Interv Cardiol       Date:  2021-02-12       Impact factor: 2.279

4.  Age-Dependent Effect of Ticagrelor Monotherapy Versus Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events: A Post Hoc Analysis of the TICO Randomized Trial.

Authors:  Byung Gyu Kim; Sung-Jin Hong; Byeong-Keuk Kim; Seung-Jun Lee; Chul-Min Ahn; Dong-Ho Shin; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Myeong-Ki Hong; Yangsoo Jang
Journal:  J Am Heart Assoc       Date:  2021-12-07       Impact factor: 5.501

5.  Polymer-free Biolimus-A9 coated thin strut stents for patients at high bleeding risk 1-year results from the LEADERS FREE III study.

Authors:  Franz R Eberli; Hans-Peter Stoll; Philip Urban; Marie-Claude Morice; Philippe Brunel; Luc Maillard; Janus Lipiecki; Stephane Cook; Jacques Berland; Thomas Hovasse; Didier Carrie; Diana Schütte; Sara Sadozai Slama; Philippe Garot
Journal:  Catheter Cardiovasc Interv       Date:  2021-07-09       Impact factor: 2.585
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.